美國居民不適用 XM 服務。

Texas Instruments: don’t mess with Elliott



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BREAKINGVIEWS-Texas Instruments: don’t mess with Elliott</title></head><body>

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

By Pranav Kiran

TORONTO, June 7 (Reuters Breakingviews) -Texas Instruments TXN.O is shrewdly trying to capitalize on the microchip boom, but its ambition reflects the idea that everything’s bigger in its namesake home state. Even after generous U.S. subsidies to help build new manufacturing facilities, it will take significant growth in customer orders and market share to justify the spending. Pushy investor Elliott Investment Management makes a reasonable case that there’s scope to cut the plans down to size.

The $175 billion company’s analog semiconductors process signals from sensors measuring temperature, pressure and more. Over the years, it has increasingly catered to industrial and automotive users, which accounted for about three-quarters of revenue last year.

Dallas-based Texas Instruments is counting on higher demand from carmakers. It intends to spend $5 billion annually, excluding taxpayer-funded help, on capital expenditures through 2026 to build and equip factories. All the investment would support $30 billion of revenue by 2026, nearly double what analysts are estimating for this year according to LSEG, and $45 billion by 2030.

Such expansion makes sense up to a point. First, the U.S. government is backstopping chipmakers to secure supply domestically. Texas Instruments expects to receive about $4 billion of assistance. Its end markets also are expected to account for more than a third of the growth in semiconductors worldwide.

Even so, there are signs that boss Haviv Ilan is overspending. American chipmakers typically invest about 30% of revenue annually on capex and research and development combined, according to the Semiconductor Industry Association trade group. Texas Instruments is earmarking 44% of this year’s projected sales, and by 2026 it’s still due to be an above-average 35% using LSEG data.

It’s one reason why Elliott is urging greater discipline. It notes that the company’s projects will lift capacity 50% beyond the $20 billion of revenue expected in 2026, using estimates compiled by Visible Alpha. Instead, the hedge fund is proposing a more flexible strategy to satisfy demand that it reckons will plump free cash flow, which has declined 75% since Texas Instruments unveiled its capital management plans in 2022.

Although Texas Instruments shares have lagged the S&P 500 Semiconductors and Semiconductor Equipment Index .SPLRCSE over the past five years, they command 23 times expected EBITDA for the next 12 months. The valuation multiple exceeds that of smaller peers Intel INTC.O and NXP Semiconductors NXPI.O, and implies excessive optimism about the company’s ability to grow revenue. Sometimes it pays to mess with Texas.

Follow @PranavKiranBV on X


CONTEXT NEWS

Elliott Investment Management on May 28 disclosed a $2.5 billion stake in Texas Instruments and urged the chipmaker to improve its free cash flow.

In a letter to the Texas Instruments board, the hedge fund firm proposed the introduction of a "dynamic capacity-management strategy," which it said would lead to free cash flow of as much as $9 a share by 2026. It added that the company’s targeted revenue capacity of $30 billion in 2026 is "far in excess of expected demand."

Texas Instruments CEO Haviv Ilan said on May 30 that he was reviewing Elliott’s suggestions and was looking forward to a “constructive dialogue” with the firm.



Editing by Jeffrey Goldfarb, Sharon Lam and Streisand Neto

</body></html>

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明